MedTrace Logo

The Communication of Genetic Risk to Adolescent Daughters of Women With Breast Cancer

NCT00588705 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 27

Last updated 2017-01-30

No results posted yet for this study

Summary

The purpose of this study is to first understand how MSKCC Clinical Genetics Service doctors talk to women with breast cancer about any genetic risks they might carry, and if they help women to think about what they might say, in turn, to their relatives, especially their daughters.

A second part of the study asks women for their opinions about when and how their daughters should be told about any genetic risks.

All of this will help us develop teaching methods to help our doctors improve the way they talk about genetic risk when women with breast cancer have adolescent daughters.

Conditions

Interventions

BEHAVIORAL

focus group & questionaire

The focus group will last about 90 minutes. However, your involvement in this study will last from the time you join until you read over the summary of what happened during the focus group and return your comments. This should be approximately 2 months. Patient will complete a questionnaire and we estimate total time for completion to be approximately 7 minutes.

Sponsors & Collaborators

Principal Investigators

  • Smita Banerjee, PhD · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
12 Years
Max Age
20 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-12-31
Primary Completion
2017-01-31
Completion
2017-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00588705 on ClinicalTrials.gov